Oxbow Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,261
| Closed | -$269K | – | 227 |
|
|
2024
Q3 | $269K | Hold |
2,261
| – | – | 0.03% | 175 |
|
|
2024
Q2 | $323K | Buy |
2,261
+465
| +26% | +$66.4K | 0.04% | 177 |
|
|
2024
Q1 | $231K | Buy |
+1,796
| New | +$231K | 0.03% | 192 |
|
|
2018
Q3 | – | Sell |
-66,576
| Closed | -$1.54M | – | 306 |
|
|
2018
Q2 | $1.54M | Buy |
66,576
+1,984
| +3% | +$45.7K | 0.2% | 114 |
|
|
2018
Q1 | $1.59M | Buy |
64,592
+2,380
| +4% | +$58.6K | 0.32% | 87 |
|
|
2017
Q4 | $1.67M | Sell |
62,212
-800
| -1% | -$21.5K | 0.31% | 94 |
|
|
2017
Q3 | $1.52M | Sell |
63,012
-2,638
| -4% | -$63.5K | 0.29% | 97 |
|
|
2017
Q2 | $1.41M | Buy |
+65,650
| New | +$1.41M | 0.25% | 109 |
|